The global veterinary infectious diseases therapeutics market is expected to grow at a significant CAGR during the forecast period (2021-2027). Microorganisms, such as bacteria and viruses, are tiny living entities that can be found everywhere. Only a few of the hundreds of microbe species invading, multiplying, and causing sickness in animals and humans. Most germs dwell on the skin, in the mouth, upper airways, and intestines without causing disease, however, depending on the nature of the microorganism and the level of the pet's natural defenses, certain microbes live in or on a pet, or invade and cause disease.

According to the World Small Animal Veterinary Association (WSAVA), zoonotic diseases account for 60% to 80% of new diseases, emphasizing the necessity of veterinarians in the detection, prevention, and control of infectious diseases. Rift Valley Fever, is an endemic zoonotic disease that costs farmers $427 million each year in Africa and the Middle East. The primary driving drivers in the veterinary infectious disease therapeutics market are the rising prevalence of infectious disease and the rising demand for dairy, meat, and poultry products.

Antibiotics are commonly used to treat infectious disorders caused by bacteria and other germs in veterinary medicine. Antibiotics such as penicillins, cephalosporins, cephamycins, aminoglycosides, and others are available for the treatment of infectious infections in animals. Infectious diseases caused by infections, germs, and parasites that transfer between animals and humans are known as zoonotic diseases. According to the Centers for Disease Control and Prevention, zoonotic infections resulted in 24,484 foodborne illnesses, 5,677 hospitalizations, and 122 fatalities in 2017. As a result, the market is predicted to rise owing to the rising number of zoonotic diseases, rising pet ownership, and increased research and development (R&D) efforts in veterinary treatments.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Elanco Animal Health Inc., Zoetis Inc., Merck & Co., Inc., and Boehringer Ingelheim International GmbH, among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Veterinary Infectious Diseases Therapeutics Market Report Segmentation

By Product Type 

• Antibiotics

• Antiviral

• Antifungal

• Amebicides

• Others

By Animal 

• Dogs and Cats

• Horses

• Swine

• Poultry

• Other

Global Veterinary Infectious Diseases Therapeutics Market by Region